UnitedHealth Group Incorporated (UNH) Price Target Raised to $228.00

UnitedHealth Group Incorporated (NYSE:UNH) had its price objective lifted by Piper Jaffray Companies to $228.00 in a research report sent to investors on Tuesday morning, The Fly reports. Piper Jaffray Companies currently has an overweight rating on the healthcare conglomerate’s stock.

Several other brokerages also recently weighed in on UNH. Zacks Investment Research downgraded shares of UnitedHealth Group from a buy rating to a hold rating in a research note on Tuesday, October 10th. Morgan Stanley upped their target price on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an overweight rating in a research note on Wednesday, June 28th. ValuEngine downgraded shares of UnitedHealth Group from a buy rating to a hold rating in a research note on Thursday, October 5th. Sanford C. Bernstein reaffirmed an outperform rating and set a $190.00 target price on shares of UnitedHealth Group in a research note on Monday, July 10th. Finally, Deutsche Bank AG upped their target price on shares of UnitedHealth Group from $187.00 to $197.00 and gave the stock a buy rating in a research note on Thursday, July 13th. Three analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. UnitedHealth Group has a consensus rating of Buy and a consensus target price of $215.27.

Shares of UnitedHealth Group (UNH) traded up 1.28% during trading on Tuesday, reaching $205.85. 1,067,908 shares of the company traded hands. The company has a market capitalization of $203.59 billion, a price-to-earnings ratio of 23.37 and a beta of 0.63. UnitedHealth Group has a 52 week low of $133.03 and a 52 week high of $207.80. The firm’s 50 day moving average price is $197.17 and its 200-day moving average price is $185.63.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the prior year, the firm earned $2.17 EPS. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group will post $9.91 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://ledgergazette.com/2017/10/20/unitedhealth-group-incorporated-unh-price-target-raised-to-228-00.html.

In other news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the transaction, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders sold a total of 76,174 shares of company stock valued at $14,981,909 in the last quarter. Insiders own 0.89% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Osborn Williams & Donohoe LLC increased its holdings in shares of UnitedHealth Group by 6.1% in the 3rd quarter. Osborn Williams & Donohoe LLC now owns 14,006 shares of the healthcare conglomerate’s stock valued at $2,743,000 after purchasing an additional 810 shares in the last quarter. Curbstone Financial Management Corp increased its holdings in shares of UnitedHealth Group by 74.7% in the 3rd quarter. Curbstone Financial Management Corp now owns 3,800 shares of the healthcare conglomerate’s stock valued at $744,000 after purchasing an additional 1,625 shares in the last quarter. MPS Loria Financial Planners LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $1,254,000. Intl Fcstone Inc. purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $2,324,000. Finally, RNC Capital Management LLC increased its holdings in shares of UnitedHealth Group by 0.7% in the 2nd quarter. RNC Capital Management LLC

Several other brokerages also recently weighed in on UNH. Zacks Investment Research downgraded shares of UnitedHealth Group from a buy rating to a hold rating in a research note on Tuesday, October 10th. Morgan Stanley upped their target price on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an overweight rating in a research note on Wednesday, June 28th. ValuEngine downgraded shares of UnitedHealth Group from a buy rating to a hold rating in a research note on Thursday, October 5th. Sanford C. Bernstein reaffirmed an outperform rating and set a $190.00 target price on shares of UnitedHealth Group in a research note on Monday, July 10th. Finally, Deutsche Bank AG upped their target price on shares of UnitedHealth Group from $187.00 to $197.00 and gave the stock a buy rating in a research note on Thursday, July 13th. Three analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. UnitedHealth Group has a consensus rating of Buy and a consensus target price of $215.27.

Shares of UnitedHealth Group (UNH) traded up 1.28% during trading on Tuesday, reaching $205.85. 1,067,908 shares of the company traded hands. The company has a market capitalization of $203.59 billion, a price-to-earnings ratio of 23.37 and a beta of 0.63. UnitedHealth Group has a 52 week low of $133.03 and a 52 week high of $207.80. The firm’s 50 day moving average price is $197.17 and its 200-day moving average price is $185.63.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the prior year, the firm earned $2.17 EPS. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group will post $9.91 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://ledgergazette.com/2017/10/20/unitedhealth-group-incorporated-unh-price-target-raised-to-228-00.html.

In other news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total transaction of $969,900.00. Following the completion of the transaction, the director now owns 76,058 shares of the company’s stock, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders sold a total of 76,174 shares of company stock valued at $14,981,909 in the last quarter. Insiders own 0.89% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Osborn Williams & Donohoe LLC increased its holdings in shares of UnitedHealth Group by 6.1% in the 3rd quarter. Osborn Williams & Donohoe LLC now owns 14,006 shares of the healthcare conglomerate’s stock valued at $2,743,000 after purchasing an additional 810 shares in the last quarter. Curbstone Financial Management Corp increased its holdings in shares of UnitedHealth Group by 74.7% in the 3rd quarter. Curbstone Financial Management Corp now owns 3,800 shares of the healthcare conglomerate’s stock valued at $744,000 after purchasing an additional 1,625 shares in the last quarter. MPS Loria Financial Planners LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $1,254,000. Intl Fcstone Inc. purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $2,324,000. Finally, RNC Capital Management LLC increased its holdings in shares of UnitedHealth Group by 0.7% in the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after purchasing an additional 13 shares in the last quarter. Institutional investors and hedge funds own 86.11% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply